SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-000486
Filing Date
2021-01-07
Accepted
2021-01-07 16:05:31
Documents
26
Period of Report
2021-01-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10018746_8k.htm 8-K 18464
2 EXHIBIT 99.1 brhc10018746_ex99-1.htm EX-99.1 39565
3 brhc10018746_ex99-1slide1.jpg GRAPHIC 123993
4 brhc10018746_ex99-1slide2.jpg GRAPHIC 198651
5 brhc10018746_ex99-1slide3.jpg GRAPHIC 170563
6 brhc10018746_ex99-1slide4.jpg GRAPHIC 161988
7 brhc10018746_ex99-1slide5.jpg GRAPHIC 198126
8 brhc10018746_ex99-1slide6.jpg GRAPHIC 115409
9 brhc10018746_ex99-1slide7.jpg GRAPHIC 170917
10 brhc10018746_ex99-1slide8.jpg GRAPHIC 183772
11 brhc10018746_ex99-1slide9.jpg GRAPHIC 171863
12 brhc10018746_ex99-1slide10.jpg GRAPHIC 183955
13 brhc10018746_ex99-1slide11.jpg GRAPHIC 133658
14 brhc10018746_ex99-1slide12.jpg GRAPHIC 162896
15 brhc10018746_ex99-1slide13.jpg GRAPHIC 178841
16 brhc10018746_ex99-1slide14.jpg GRAPHIC 111747
17 brhc10018746_ex99-1slide15.jpg GRAPHIC 146688
18 brhc10018746_ex99-1slide16.jpg GRAPHIC 162376
19 brhc10018746_ex99-1slide17.jpg GRAPHIC 235365
20 brhc10018746_ex99-1slide18.jpg GRAPHIC 206835
21 brhc10018746_ex99-1slide19.jpg GRAPHIC 208111
22 brhc10018746_ex99-1slide20.jpg GRAPHIC 176546
23 brhc10018746_ex99-1slide21.jpg GRAPHIC 99680
24 brhc10018746_ex99-1slide22.jpg GRAPHIC 160543
25 brhc10018746_ex99-1slide23.jpg GRAPHIC 144114
26 brhc10018746_ex99-1slide24.jpg GRAPHIC 90229
  Complete submission text file 0001140361-21-000486.txt   5429068
Mailing Address 25B VREELAND ROAD FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 21514249
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences